Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019.

ABSTRACT:

Background

In 2017, San Francisco's initiative to locally eliminate hepatitis C virus (HCV) as a public health threat, End Hep C SF, generated an estimate of city-wide HCV prevalence in 2015, but only incorporated limited information about population HCV treatment. Using additional data and updated methods, we aimed to update the 2015 estimate to 2019 and provide a more accurate estimate of the number of people with untreated, active HCV infection overall and in key subgroups-people who inject drugs (PWID), men who have sex with men (MSM), and low socioeconomic status transgender women (low SES TW).

Methods

Our estimates are based on triangulation of data from blood bank testing records, cross-sectional and longitudinal observational studies, and published literature. We cal

SUBMITTER: Facente SN 

PROVIDER: S-EPMC9094540 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature